Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 234-217-9 | CAS number: 10599-90-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- short-term repeated dose toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: OECD Guideline study, according to GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 412 (Subacute Inhalation Toxicity: 28-Day Study)
- Deviations:
- yes
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.8 (Subacute Inhalation Toxicity: 28-Day Study)
- Deviations:
- yes
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
Test material
- Reference substance name:
- Chloramide
- EC Number:
- 234-217-9
- EC Name:
- Chloramide
- Cas Number:
- 10599-90-3
- Molecular formula:
- ClH2N
- IUPAC Name:
- chloranamine
- Test material form:
- other: aqueous solution
- Details on test material:
- - solution of Monochloramine at 1 %
- Due to the instability of the Monochloramine, the solution is prepared extemporaneously.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- 25 males and 25 females.
Duration of acclimatisation: 10 days before commencement of treatment.
Age of the main animals at start of treatment: 53 to 59 days.
Weight range of the study animals at the start of treatment: Males: 192 to 226 g / Females: 141 to 171 g
Administration / exposure
- Route of administration:
- inhalation
- Type of inhalation exposure:
- nose only
- Details on inhalation exposure:
- Route: Inhalation - snout only exposure.
Training for dosing: The animals on study were acclimated to the method of restraint, over a 3 day period preceding the first test substance exposure. - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- The formulated samples were analysed using a method transferred from the Sponsor and involved the colorimetric measurement of Total Residual Chlorine (TRC) and Free Residual Chlorine (FRC). Monochloramine was calculated from the difference between the two measurements
- Duration of treatment / exposure:
- 28 days
- Frequency of treatment:
- Duration of daily exposure: 6 hours, 5 days each week.
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
0.025
Basis:
nominal conc.
- Remarks:
- Doses / Concentrations:
0.079
Basis:
nominal conc.
- Remarks:
- Doses / Concentrations:
0.25
Basis:
nominal conc.
- No. of animals per sex per dose:
- 25 males and 25 females.
5 males and 5 females per dose - Control animals:
- yes
- Positive control:
- none
Examinations
- Observations and examinations performed and frequency:
- SERIAL OBSERVATION:
1) Clinical observations:
Animals were inspected visually at least twice daily for evidence of ill-health or reaction to treatment. Cages were inspected daily for evidence of animal ill-health amongst the occupants. Any deviation from normal was recorded at the time in respect of nature and severity, date and time of onset, duration and progress of the observed condition, as appropriate.
Signs associated with exposures
Detailed observations were recorded daily on exposure days at the following times in relation to exposure:
- Pre-exposure observation
- As each animal was returned to its home cage
- As late as possible in the working day
Detailed observations were recorded daily on non-exposure days at the following times in relation to dose administration:
- Early in the working day (equivalent to pre-exposure observation)
- As late as possible in the working day
Clinical signs
A detailed weekly physical examination was performed on each animal to monitor general health.
2) Body weight:
The weight of each animal was recorded twice during Week -1, on the day that exposures commenced (Day 1), twice weekly throughout the study and before necropsy.
3) Food consumption:
The weight of food supplied to each cage, that remaining and an estimate of any spilled was recorded for the week before treatment started and for each week throughout the study.
4) Haematology, peripheral blood:
Blood samples were collected after overnight withdrawal of food and prior to exposure during Week 4.
- Haematocrit (Hct)
- Haemoglobin concentration (Hb)
- Erythrocyte count (RBC)
- Absolute reticulocyte count (Retic)
- Mean cell haemoglobin (MCH)
- Mean cell haemoglobin concentration (MCHC)
- Mean cell volume (MCV)
- Red cell distribution width (RDW)
- Total leucocyte count (WBC)
- Differential leucocyte count: Neutrophils (N), Lymphocytes (L), Eosinophils (E), Basophils (B), Monocytes (M), Large unstained cells (LUC), Platelet count (Plt)
Additional blood samples (nominally 0.5 mL) were taken into tubes containing citrate anticoagulant and examined using an ACL series analyser and appropriate reagent in respect of:
- Prothrombin time (PT) - using IL PT-Fibrinogen reagent.
- Activated partial thromboplastin time (APTT) - using IL APTT reagent.
5) Haematology, bone marrow:
Bone marrow smears were prepared immediately following death, on completion of the scheduled treatment period.
6) Blood chemistry:
Blood samples were collected after overnight withdrawal of food and prior to exposure during Week 4.
- Alkaline phosphatase (ALP)
- Alanine aminotransferase (ALT)
- Aspartate aminotransferase (AST)
- Gamma-glutamyl transpeptidase (gGT)
- Total bilirubin (Bili)
- Urea
- Creatinine (Creat)
- Glucose (Gluc)
- Total cholesterol (Chol)
- Triglycerides (Trig)
- Sodium (Na)
- Potassium (K)
- Chloride (Cl)
- Calcium (Ca)
- Inorganic phosphorus (Phos)
- Total protein (Total Prot)
- Albumin (Alb)
- Albumin/globulin ratio (A/G Ratio) was calculated from total protein concentration and analysed albumin concentration. - Sacrifice and pathology:
- TERMINAL PROCEDURES:
All main study animals were subject to a detailed necropsy. After a review of the history of each animal, a full macroscopic examination of the tissues was performed. All external features and orifices were examined visually. Any abnormality in the appearance or size of any organ and tissue (external and cut surface) was recorded and the required tissue samples preserved in appropriate fixative.
The retained tissues were checked before disposal of the carcass.
Schedule Animals were killed following 4 weeks of exposures.
The organs weighed, tissue samples fixed and sections examined microscopically are detailed in the table 1 "in "any other information on material and methods"
For bilateral organs, left and right organs were weighed together, unless specified above. Requisite organs were weighed for animals killed at scheduled intervals.
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Description (incidence and severity):
- .
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- no effects observed
- Details on results:
- 1) Clinical observations
Clinical signs associated with exposures for females exposed to 0.287 μg/L included abnormal gait (elevated, swaying, unsteady), these signs were observed on occasion on return to the home cage and remained evident until the end of day observations. There were no clinical signs on the days without exposures (Days 6-7, 13-14, 20-21, 27-28). Clinical signs of red staining to the nose, eyes and head were observed for a proportion of animals from all groups, the incidence of these signs was increased in test groups. Wet fur was observed on return to the home cage on occasion for all groups. These signs were considered to be due to the method of administration.
2) Body weight
There were no test article related effects on body weight.
3) Food consumption
There were no test article related effects on food consumption.
4) Haematology, peripheral blood
There were no test article related effects.
Mean white blood cell counts were lower for all males exposed to monochloramine and females exposed to 0.287 μg/L, principally due to neutrophils and lymphocytes. This finding lacked an exposure relationship for males and all individual values were within the background data range, therefore this was considered not to be test article related. All other differences from control were generally small, inconsistent between the sexes or considered to be due to high intra-group variation and therefore were not of toxicological importance.
5) Blood chemistry
Mean phosphorus concentration was low for males exposed to 0.0767 or 0.287 μg/L and all females exposed to monochloramine, when compared with control (as low as 0.89X and 0.77X control, for males and females, respectively (exposure related in females only)). All other differences from control were generally small, inconsistent between the sexes, lacked exposure-relationship or were considered to be due to high intra-group variation and therefore were not of toxicological importance.
6) Organ weights
Mean heart weight was low for all females exposed to monochloramine (unadjusted and adjusted), compared with control (as low as 0.80X), however this finding lacked an exposure relationship.
7) Macropathology
The macroscopic examination performed after 4 weeks of exposures revealed no test substance related lesions. The incidence and distribution of all findings were consistent with the common background seen here.
8) Histopathology
No changes related to treatment with monochloramine were seen. All histological findings were considered incidental and unrelated to the test article.
Effect levels
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- 0.287 mg/L air (analytical)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- histopathology: non-neoplastic
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
1) Formulation analysis:
The formulation concentrations were within 10% of nominal inclusion apart from Week/Day 3.2 for Group 4 which was 116% of nominal inclusion. The pH measurements for all formulations ranged between pH 10.15 and pH 11.13.
2) Atmosphere analysis and estimation of achieved dose:
Group |
Vapour concentration (µg/L)
|
|
Target |
Achieved |
|
2 |
0.025 |
0.0294 |
3 |
0.079 |
0.0767 |
3 |
0.25 |
0.287 |
The achieved daily mean vapour concentrations were 118, 97 and 115% of the target concentration. The pH measurements from the concentration samples ranged between pH 6.04 and pH 8.09.
Applicant's summary and conclusion
- Conclusions:
- Administration of monochloramine vapour, by the inhaled route to Han Wistar rats, 6 hours daily, for 4 weeks at achieved vapour concentrations of 0.0294, 0.0767 or 0.287 μg/L was well tolerated.
Test article-related findings were limited to clinical observations, which were transient in nature and therefore considered non-adverse. There were no other clinical or pathological reactions to exposure to monochloramine. Based on the results of this study the No Observed Adverse Effect Level (NOAEL) is considered to be greater than 0.287 μg/L, the No Observed Effect Level (NOEL) was considered to be 0.0767 μg/L. - Executive summary:
The objective of this study was to assess the toxic potential of monochloramine, in a 4 weeks inhalation study to Han Wistar rats according to OECD Guideline 412 and EC Method B8. The inhalation route of administration was chosen to simulate the conditions of potential human exposure.
A previous preliminary test was performed in order to determine the test dose to be performed in the definitive test. In this preliminary study of the repeated dose toxicity study 28 days, firstly Han Wistar rats were exposed to monochloramine vapour at 18.8 or 53.5 μg/L for 6 hours a day. Exposure of monochloramine vapour at 18.8 or 53.5 μg/L for 2 days was not tolerated and animals were euthanized on Day 3. Histopathological changes were observed in the respiratory system and were suggestive of acute irritation. Secondly, Han Wistar rats were exposed five days for 6 hours a day at 0.233, 0.649 or 1.88 μg/L, followed by a two day off exposure period. This exposure resulted in test article related breathing signs. The incidence of these signs at 0.649 and 1.88 μg/L and the likely progression indicate that these vapour concentrations would not be suitable for longer term administration. The findings at 0.233 μg/L were of lesser severity, it is therefore anticipated that target vapour concentrations up to this threshold would be tolerated in a longer term study.
In this study, 3 groups of 5 males and 5 females Han Wistar rats were exposed to monochloramine vapour, by the inhaled route 6 hours daily, for 4 weeks at the target nominal vapour concentrations of 0.025, 0.079 or 0.25 μg/L. During the study, clinical condition, body weight, food consumption, haematology (peripheral blood), blood chemistry, organ weight, macropathology and histopathology investigations were undertaken. This administration of monochloramine vapour at the achieved vapour concentrations of 0.0294, 0.0767 or 0.287 μg/L was well tolerated. There were no test-article related effects on body weight, food consumption or haematology parameters. There were also no macroscopic or microscopic changes. There were no treatment-related unscheduled deaths during the study and no relevant clinical signs were observed. Test article-related findings were limited to clinical observations, which were transient in nature and therefore considered non-adverse. There were no other clinical or pathological reactions to exposure to monochloramine. Based on the results of this study the No Observed Adverse Effect Level (NOAEL) is considered to be greater than 0.287 μg/L, the No Observed Effect Level (NOEL) was considered to be 0.0767 μg/L.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.